IP Library › Granted Patent US 7,357,924
Granted Patent B2
US 7,357,924 · App. 10/705,183 · Granted Apr 15, 2008

Uses of IL-174 for treating helminth infections

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,357,924
App. No.
10/705,183
Granted
Apr 15, 2008
Kind
B2
Abstract

Use of the cytokine designated IL-174 to treat infectious diseases such as helminth infections.

Claims (3)

1. A method of treating a Helminth infection in a patient, comprising administering an IL-174 agonist to the patient, wherein the IL-174 agonist is a human IL-174 protein which consists of SEQ ID NO:2.

2. A method of treating a Helminth infection in a patient, comprising administering an IL-174 agonist to the patient, wherein the IL-174 agonist is a human IL-174 protein which comprises the amino acid sequence from Tyr at position 1 SEQ ID NO:2 through Gly at position 145 of SEQ ID NO:2.

3. A method of treating a Helminth infection in a patient, comprising administering an IL-174 agonist to the patient, wherein the IL-174 agonist a human IL-174 protein which consists of the amino acid sequence from Tyr position 1 of SEQ ID NO:2 through Gly at position 145 of SEQ ID NO:2.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →